HER2 Low Breast Neoplasms

Oncology

Prevalence

287.0 / 100K

Incidence

128.0 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target HER2 Low Breast Neoplasms?

There are 1 clinical trial targeting HER2 Low Breast Neoplasms tracked by BioSniper.

What is the prevalence of HER2 Low Breast Neoplasms?

The estimated prevalence of HER2 Low Breast Neoplasms is approximately 287.0 per 100,000 population.

Deep-dive into HER2 Low Breast Neoplasms

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    HER2 Low Breast Neoplasms — Drugs in Development & Clinical Trials | BioSniper